Chronic Kidney Disease and GLP-1 RAs

Please note: AHA does not associate with, nor endorse YouTube recommendations.

Conversation around current considerations for use of GLP-1 RAs in people with type 2 diabetes and chronic kidney disease (CKD). The discussion will include general considerations for management of diabetes in CKD, potential benefits of GLP-1 RA therapy in CKD (e.g., glycemic lowering, CV risk reduction, potential kidney benefits), and a discussion of contemporary guideline recommendations for GLP-1 RA use in this population.

Claim CE and MOC Credit at https://bit.ly/4aNc3t8

Recommended Videos
Assessment of Insomnia in an Office Visit
Medications to Treat Insomnia
Diagnosing Medication Non-Adherence in Hypertension Treatment
Therapeutic Inertia and Medication Non-Adherence in Hypertension Treatment
What to do if an Incidental Cardiovascular Variant is Identified
saved video
Save Video

Please note: AHA does not associate with, nor endorse YouTube recommendations.

See Full Content
Video is not available. Please check the URL.